Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Header
Newsroom
Showing 386 results
January 2021
-
Story Patient Perspectives
Digital innovation looks set to dominate the 2021 healthcare agenda
Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.
-
Story Patient Perspectives
Turning the sound up on patient voices in lung cancer research and development
Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.
-
Story Patient Perspectives
AI Nurse evolving for heart failure patients in China
Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.
November 2020
-
Story Discovery
New hope for treating inflammatory diseases of the kidney
Novartis researchers aim to preserve kidney function – and quality of life – for patients.
-
Story Discovery
Predictive analytics could bring medicines to patients faster
Novartis researchers are using data to accelerate drug development.
-
Story Discovery
Making Possible: Stepping toward a future with cell and gene therapy
These stories offer a glimpse into the lives of people touched by a new era of medicine.
-
Story Discovery
Need for new heart disease medicines drives wave of potential therapies
Novartis is investing in a novel type of medicine to reduce the risk of heart disease.
September 2020
-
Story Access to Healthcare
Chagas disease: Breaking the silence
Explaining Chagas disease through the stories of patients in Latin America.
-
Story Patient Perspectives
Speaking Up in CML
Lisa, a patient living with CML, shares her experience and discusses the importance of speaking up about unmet needs in your disease.
-
Story Discovery
Bringing science and medicine together to help patients with cancer
Alice Shaw, Global Head of Translational Clinical Oncology at Novartis, applies lessons from running clinical trials to the work of designing them.